Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 13 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 9102. Clear
Clear
Q2
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code
View → Q2
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Trade (domestic/foreign), Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View → Q2
AMGEN, INC. for AMGEN INC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
FDD ACTION for FDD ACTION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Banking, Defense, Foreign Relations, Homeland Security
View → Q2
PFIZER INC. for PFIZER INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View → Q2
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View → Q2
ALSTON & BIRD LLP for CURIE BIO OPERATIONS, LLC
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $130,000.00 income
Financial Institutions/Investments/Securities, Health Issues, Banking, Budget/Appropriations
View → Q2
CORNERSTONE GOVERNMENT AFFAIRS, INC. for JOHNS HOPKINS UNIVERSITY
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $60,000.00 income
Budget/Appropriations, Education, Medicare/Medicaid, Taxation/Internal Revenue Code
View → Q2
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View → Q2
TIBER CREEK GROUP for ASTRAZENECA
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $80,000.00 income
Health Issues, Foreign Relations, Defense, Medicare/Medicaid
View → Q2
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem